TWiV 901: COVID-19 clinical update #115 with Dr. Daniel Griffin

<p>In COVID-19 clinical update #115, Dr. Griffin reviews cross-variant immunity without vaccination, EUA for boosters in 5-11 year olds, B.1.1.529 attack rate, scent dogs, Omicron and pets, Paxlovid, Veklury, Fluvoxamine, antigen positivity after isolation, inflammasome activation and severe disease, and GI persistence and fecal shedding.</p> <p>Subscribe (free): <a title= "http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784" href= "https://podcasts.apple.com/us/podcast/this-week-in-virology/id1176779065">Apple Podcasts</a>, <a href= "https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D">Google Podcasts</a>, <a href= "http://twiv.microbeworld.libsynpro.com/twiv">RSS</a>, <a href="http://eepurl.com/Gcw59">email</a></p> <p>Become a <a href= "https://www.microbe.tv/contribute">patron</a> of TWiV!</p> <h3 id="links-for-this-episode"><strong>Links for this episode</strong></h3> <ul> <li>Limited <a href= "https://www.nature.com/articles/s41586-022-04865-0">cross-variant immunity</a> without vaccination (Nature)</li> <li><a href= "https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-pfizer-biontech-covid-19-vaccine-booster-dose"> EUA for boosters</a> in 5-11 year olds (FDA)</li> <li><a href= "https://www.aidsreviews.com/resumen.php?id=1567&indice=2020224&u=unp"> Stages</a> of COVID-19 (AIDS Rev)</li> <li><a href= "https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiac184/6582820"> B.1.1.529 attack rate</a> in Australia (JID)</li> <li><a href="https://gh.bmj.com/content/7/5/e008024?rss=1">Scent dogs</a> (BMJ)</li> <li>Does Omicron <a href= "https://vetmed.tamu.edu/news/pet-talk/does-the-covid-19-omicron-variant-spread-affect-pets/"> affect pets?</a> (CVMBS News)</li> <li>Paxlovid <a href= "https://www.fda.gov/media/158165/download">eligibility checklist</a> (FDA)</li> <li>Supratherapeutic tacrolimus with <a href= "https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofac238/65